✨ Free AI Report
IM Cannabis Corp.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research IM Cannabis Corp.
Company Research

IM Cannabis Corp.: Business Overview, Financials & Competitive Analysis

IM Cannabis is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The company recently exited operations i...

Analyst-debate audio for IM Cannabis Corp.

AskCyborg analysts argue the bull and bear cases for IM Cannabis Corp. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
4/ 10Mixed

Cyborg Score thesis

Established medical cannabis player in regulated markets faces liquidity pressure while exploring strategic diversification and...

Read the full analyst-debate transcript →
Industry Medical Cannabis Manufacturing & Distribution
2 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest IM Cannabis Corp. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

IM Cannabis Corp. Overview

Pro stress-test →

IM Cannabis is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The company recently exited operations in Canada to pivot focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany.

Strategic Profile

Pro stress-test →

IM Cannabis leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. The company operates medical cannabis retail pharmacies, online platforms, and distribution centers in Israel, and in Germany distributes cannabis to pharmacies through Adjupharm GmbH, which also offers fulfillment services using its EU-GMP packing facility and GDP logistics center.

Competitive Landscape

Pro stress-test →

IM Cannabis provides medical cannabis dried flowers and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company operates in highly regulated medical cannabis markets in Israel and Germany, competing primarily with other licensed cultivators and distributors in these jurisdictions.

Industry Context

IM Cannabis Corp. operates in Medical Cannabis Manufacturing & Distribution.

Key facts

Founded: 2008 · Headquarters: Tel Aviv, Israel

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on IM Cannabis Corp..

  • Company exited Canadian operations to focus on higher-value Israel and Germany markets
  • Raised US$2.17M debt financing in January 2026 to address liquidity needs
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • January 2026Raised US$2.17M in convertible note financing to manage liquidity
  • December 2025Appointed Alon Dayan to board for homeland security technology expertise
  • +2 moreTrack every material event for IM Cannabis Corp. as it happens. Explore monitoring →
Get alerted when IM Cannabis Corp. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Medical Cannabis - EuropeEU-licensed medical cannabis suppliers in Germany→Israeli Medical Cannabis ProvidersLicensed suppliers in Israeli medical cannabis market→

Compare IM Cannabis Corp. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

IM Cannabis Corp. operates in Medical Cannabis Manufacturing & Distribution. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Cannabis Manufacturing & Distribution research →
NEW · MCP server

Ask your AI assistant about IM Cannabis Corp.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare IM Cannabis Corp. and its top competitor on Cyborg Score”
“What did IM Cannabis Corp. do this quarter?”
“Is IM Cannabis Corp. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does IM Cannabis Corp. do?+
IM Cannabis is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The company recently exited operations i...
What is IM Cannabis Corp.'s Cyborg Score?+
IM Cannabis Corp. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are IM Cannabis Corp.'s main competitors?+
Named competitors include Medical Cannabis - Europe, Israeli Medical Cannabis Providers. The full competitive landscape is in the AskCyborg report.
How can I get the full IM Cannabis Corp. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the IM Cannabis Corp. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track IM Cannabis Corp. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.